BTC Health Ltd (BTC) - Total Assets
Based on the latest financial reports, BTC Health Ltd (BTC) holds total assets worth AU$11.31 Million AUD (≈ $8.01 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See BTC net assets for net asset value and shareholders' equity analysis.
BTC Health Ltd - Total Assets Trend (2000–2025)
This chart illustrates how BTC Health Ltd's total assets have evolved over time, based on quarterly financial data.
BTC Health Ltd - Asset Composition Analysis
Current Asset Composition (June 2025)
BTC Health Ltd's total assets of AU$11.31 Million consist of 6.8% current assets and 93.2% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$620.11K | 6.6% |
| Accounts Receivable | AU$0.00 | 0.0% |
| Inventory | AU$0.00 | 0.0% |
| Property, Plant & Equipment | AU$0.00 | 0.0% |
| Intangible Assets | AU$0.00 | 0.0% |
| Goodwill | AU$0.00 | 0.0% |
Asset Composition Trend (2000–2025)
This chart illustrates how BTC Health Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see BTC stock market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: BTC Health Ltd's current assets represent 6.8% of total assets in 2025, a decrease from 100.0% in 2000.
- Cash Position: Cash and equivalents constituted 6.6% of total assets in 2025, down from 100.0% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2000.
- Asset Diversification: The largest asset category is cash and equivalents at 6.6% of total assets.
BTC Health Ltd Competitors by Total Assets
Key competitors of BTC Health Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $7.59 Billion |
|
Ascendis Pharma AS
F:A71
|
Germany | €1.30 Billion |
|
Summit Therapeutics PLC
NASDAQ:SMMT
|
USA | $261.73 Million |
|
Xiamen Amoytop Biotech Co Ltd
SHG:688278
|
China | CN¥3.21 Billion |
|
Sinopep-Allsino Biopharmaceutical Co. Ltd. A
SHG:688076
|
China | CN¥6.69 Billion |
|
Wuhan Keqian Biology Co Ltd
SHG:688526
|
China | CN¥4.75 Billion |
|
R&G PharmaStudies Co. Ltd. A
SHE:301333
|
China | CN¥2.31 Billion |
|
Shanghai Shen Lian Biomedical Corp
SHG:688098
|
China | CN¥1.56 Billion |
BTC Health Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 22.45 | 3.75 | 13.59 |
| Quick Ratio | 22.45 | 3.75 | 13.59 |
| Cash Ratio | 22.45 | 3.44 | 13.47 |
| Working Capital | AU$1.57 Million | AU$635.57K | AU$2.16 Million |
BTC Health Ltd - Advanced Valuation Insights
This section examines the relationship between BTC Health Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.78 |
| Latest Market Cap to Assets Ratio | 1.46 |
| Asset Growth Rate (YoY) | 81.8% |
| Total Assets | AU$9.36 Million |
| Market Capitalization | $13.66 Million USD |
Valuation Analysis
Above Book Valuation: The market values BTC Health Ltd's assets above their book value (1.46x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: BTC Health Ltd's assets grew by 81.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for BTC Health Ltd (2000–2025)
The table below shows the annual total assets of BTC Health Ltd from 2000 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | AU$9.36 Million ≈ $6.62 Million |
+81.76% |
| 2024-06-30 | AU$5.15 Million ≈ $3.64 Million |
+75.03% |
| 2023-06-30 | AU$2.94 Million ≈ $2.08 Million |
-77.40% |
| 2022-06-30 | AU$13.02 Million ≈ $9.21 Million |
+0.26% |
| 2021-06-30 | AU$12.98 Million ≈ $9.19 Million |
+13.33% |
| 2020-06-30 | AU$11.46 Million ≈ $8.11 Million |
-2.24% |
| 2019-06-30 | AU$11.72 Million ≈ $8.29 Million |
+253.48% |
| 2018-06-30 | AU$3.32 Million ≈ $2.35 Million |
-28.96% |
| 2017-06-30 | AU$4.67 Million ≈ $3.30 Million |
+72.41% |
| 2016-06-30 | AU$2.71 Million ≈ $1.92 Million |
+156.85% |
| 2015-06-30 | AU$1.05 Million ≈ $745.76K |
-17.97% |
| 2014-06-30 | AU$1.28 Million ≈ $909.13K |
-59.45% |
| 2013-06-30 | AU$3.17 Million ≈ $2.24 Million |
-35.71% |
| 2012-06-30 | AU$4.93 Million ≈ $3.49 Million |
-58.05% |
| 2011-06-30 | AU$11.75 Million ≈ $8.31 Million |
-27.20% |
| 2010-06-30 | AU$16.14 Million ≈ $11.42 Million |
-31.18% |
| 2009-06-30 | AU$23.45 Million ≈ $16.59 Million |
-16.66% |
| 2008-06-30 | AU$28.14 Million ≈ $19.91 Million |
-25.87% |
| 2007-06-30 | AU$37.96 Million ≈ $26.86 Million |
-20.81% |
| 2006-06-30 | AU$47.93 Million ≈ $33.91 Million |
+12.95% |
| 2005-06-30 | AU$42.44 Million ≈ $30.03 Million |
-12.14% |
| 2004-06-30 | AU$48.30 Million ≈ $34.18 Million |
+22.69% |
| 2003-06-30 | AU$39.37 Million ≈ $27.86 Million |
-0.02% |
| 2002-06-30 | AU$39.38 Million ≈ $27.86 Million |
-1.79% |
| 2001-06-30 | AU$40.10 Million ≈ $28.37 Million |
+0.12% |
| 2000-06-30 | AU$40.05 Million ≈ $28.34 Million |
-- |
About BTC Health Ltd
BTC Health Limited is a Pooled Development Fund managed by LHC Capital Partners Pty Ltd specializing in seed/startup, early venture, mid venture, late venture, emerging growth and growth capital investments. It makes investments in the healthcare, acute pain management, neuro-spinal, cardiovascular, pharmaceutical, medical technologies, biotechnology sector with a focus on post-genomics, stem cel… Read more